MILB 13G 2003

Company

Protagenic Therapeutics, Inc.\new

Filed

February 18, 2004

Accession Number

0001051042-04-000010

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →